Clin2
NCT07313722Possibly a fitRecruiting

Testing a new eye drop for safety in healthy volunteers

Healthy

Treatments studied

This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
32 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • Be between 18 and 50 years old.
  • Have a healthy body weight (BMI between 18 and 27).
  • Have good vision (corrected to 20/25 or better) and normal eye pressure.
  • Not use contact lenses or have any ongoing eye disease or injury.
  • Be willing to avoid certain medications and alcohol during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07245017Recruiting· Early Phase 1
Testing JN002 drops for dry eye disease

This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.

Shanghai
NCT07764965Not yet recruiting· Phase 1
Testing a new eye drop in healthy volunteers

This trial tests a new eye drop called PAN-90806 in healthy people to see if it is safe and how the body handles it. Participants will receive the eye drops and be closely monitored.

NCT07370584Recruiting· Phase 1
Safety study of IVMED-85 eye drops in healthy adults

This phase 1 trial tests the safety of an investigational eye drop called IVMED-85 in healthy adults aged 18-49. Participants will receive the eye drops and be monitored for any side effects over 6 weeks.

Memphis, Tennessee
NCT06379685Not yet recruiting· Phase 1
Testing a new eye drop for safety compared to a common brand

This study tests a new eye drop called PRO-190 to see if it's safe and comfortable for the eyes, comparing it to a common artificial tear (Systane Ultra). It is for healthy people and may help if you have dry or irritated eyes.

NCT07777861Recruiting· Phase 2
Testing an eye drop for worsening glaucoma

This study tests an eye drop (G01) for people with primary open-angle glaucoma that is getting worse despite current treatments. It aims to see if G01 can safely slow down or stop the progression of glaucoma.

Beijing, Beijing Municipality
NCT07521748Not yet recruiting· Phase 1
Safety of RC017 eye ointment in healthy adults

This study tests an eye ointment (RC017) in healthy adults to check its safety and how the body processes it. It may help doctors understand if this treatment for eye conditions is safe before it's used in patients.

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.